686 related articles for article (PubMed ID: 25933820)
1. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.
Saigusa T; Bell PD
Physiology (Bethesda); 2015 May; 30(3):195-207. PubMed ID: 25933820
[TBL] [Abstract][Full Text] [Related]
2. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
Cai Y; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
[TBL] [Abstract][Full Text] [Related]
3. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease.
Ali H; Hussain N; Naim M; Zayed M; Al-Mulla F; Kehinde EO; Seaburg LM; Sundsbak JL; Harris PC
BMC Nephrol; 2015 Mar; 16():26. PubMed ID: 25880449
[TBL] [Abstract][Full Text] [Related]
4. Cilia and polycystic kidney disease.
Ma M
Semin Cell Dev Biol; 2021 Feb; 110():139-148. PubMed ID: 32475690
[TBL] [Abstract][Full Text] [Related]
5. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.
Rangan GK; Alexander SI; Campbell KL; Dexter MA; Lee VW; Lopez-Vargas P; Mai J; Mallett A; Patel C; Patel M; Tchan MC; Tong A; Tunnicliffe DJ; Vladica P; Savige J
Nephrology (Carlton); 2016 Aug; 21(8):705-16. PubMed ID: 26511892
[No Abstract] [Full Text] [Related]
6. A polycystin-centric view of cyst formation and disease: the polycystins revisited.
Ong AC; Harris PC
Kidney Int; 2015 Oct; 88(4):699-710. PubMed ID: 26200945
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
[TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
Noël N; Rieu P
Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
[TBL] [Abstract][Full Text] [Related]
9. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
Xu Y; Li A; Wu G; Liang C
Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
[TBL] [Abstract][Full Text] [Related]
10. Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
Rangan GK; Lopez-Vargas P; Nankivell BJ; Tchan M; Tong A; Tunnicliffe DJ; Savige J
Semin Nephrol; 2015 Nov; 35(6):524-37. PubMed ID: 26718155
[TBL] [Abstract][Full Text] [Related]
11. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.
Cornec-Le Gall E; Torres VE; Harris PC
J Am Soc Nephrol; 2018 Jan; 29(1):13-23. PubMed ID: 29038287
[TBL] [Abstract][Full Text] [Related]
12. Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs.
Tan YC; Blumenfeld J; Rennert H
Biochim Biophys Acta; 2011 Oct; 1812(10):1202-12. PubMed ID: 21392578
[TBL] [Abstract][Full Text] [Related]
13. Possible role of the mitochondrial genome in the pathogenesis of autosomal dominant polycystic kidney disease.
Saravanabavan S; Rangan GK
Nephrology (Carlton); 2021 Nov; 26(11):920-930. PubMed ID: 34331378
[TBL] [Abstract][Full Text] [Related]
14. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
15. Kidney enlargement and multiple liver cyst formation implicate mutations in PKD1/2 in adult sporadic polycystic kidney disease.
Fujimaru T; Mori T; Sekine A; Mandai S; Chiga M; Kikuchi H; Ando F; Mori Y; Nomura N; Iimori S; Naito S; Okado T; Rai T; Hoshino J; Ubara Y; Uchida S; Sohara E
Clin Genet; 2018 Jul; 94(1):125-131. PubMed ID: 29520754
[TBL] [Abstract][Full Text] [Related]
16. [Autosomal dominant polycystic kidney disease--research status and clinical manifestation].
Augustyniak-Bartosik H; Weyde W; Krajewska M; Klinger M
Postepy Hig Med Dosw (Online); 2004; 58():530-7. PubMed ID: 15765015
[TBL] [Abstract][Full Text] [Related]
17. Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.
Hopp K; Kleczko EK; Gitomer BY; Chonchol M; Klawitter J; Christians U; Klawitter J
Am J Physiol Renal Physiol; 2022 Mar; 322(3):F258-F267. PubMed ID: 35037466
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of polycystic kidney disease expression profiles defines strong involvement of injury repair processes.
Malas TB; Formica C; Leonhard WN; Rao P; Granchi Z; Roos M; Peters DJ; 't Hoen PA
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F806-F817. PubMed ID: 28148532
[TBL] [Abstract][Full Text] [Related]
19. Polycystic kidney disease: new horizons and therapeutic frontiers.
Czarnecki PG; Steinman TI
Minerva Urol Nefrol; 2013 Mar; 65(1):61-8. PubMed ID: 23538311
[TBL] [Abstract][Full Text] [Related]
20. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
